ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,997,000 | +15.5% | 1,218,851 | +0.6% | 0.20% | +29.2% |
Q4 2021 | $4,325,000 | +75.6% | 1,211,351 | +79.0% | 0.15% | +69.2% |
Q3 2021 | $2,463,000 | -16.8% | 676,687 | -0.3% | 0.09% | -13.3% |
Q2 2021 | $2,959,000 | +2.6% | 678,683 | -3.3% | 0.10% | +11.7% |
Q1 2021 | $2,883,000 | +20.5% | 701,499 | +17.0% | 0.09% | +11.9% |
Q4 2020 | $2,393,000 | – | 599,628 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |